Nanobiotix SA (NBTX) Earnings Date & Reports

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NBTX is expected to report earnings to fall 35.85% to -29 cents per share on September 30

Nanobiotix SA NBTX Stock Earnings Reports

Q2'26

Est.

$-0.29

Q4'25

Missed

by $0.06

Q2'25

Beat

by $0.23

Q4'24

Missed

by $0.39

Q2'24

Est.

$-0.51

The last earnings report on March 31 showed earnings per share of -45 cents, missing the estimate of -39 cents. With 11.63K shares outstanding, the current market capitalization sits at 2.02B.

View a ticker or compare two or three

Ask AI

Compare

NEWEarnings-Safe Strategy - Trading Results
AI Trading Agent (80 Tickers), 60min NEWEarnings-Safe Strategy - Trading Results
AI Trading Agent (80 Tickers), 60min

Annualized Return+36%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

NBTX

Setup

Daily Signal:

Description

Gain/Loss: